Showing results (121-130 of 416) with videos related to

Sort By:
Pageof 42
Brain Research|January 15, 1986
Zinc and paired-pulse potentiation in the hippocampusS S Khulusi, M W Brown, D M Wright
Synapse (New York, N.Y.)|July 1, 1992
ATP-sensitive K+ channels mediate an IPSP in dorsal horn neurones elicited by sensory stimulationM W Salter, Y De Koninck, J L Henry
Neuroscience Letters|July 18, 1994
Substance P released endogenously by high-intensity sensory stimulation potentiates purinergic inhibition of nociceptive dorsal horn neurons induced by peripheral vibrationY De Koninck, M W Salter, J L Henry
European Journal of Pharmacology|November 9, 2000
Neuropeptide FF attenuates allodynia in models of chronic inflammation and neuropathy following intrathecal or intracerebroventricular administrationN Altier, A Dray, D Ménard, et al.
Canadian Journal of Physiology and Pharmacology|November 1, 1990
Adrenal versus nonadrenal sympathetic preganglionic neurones in the lower thoracic intermediolateral nucleus of the cat: physiological propertiesS B Backman, H Sequeira-Martinho, J L Henry
Cancer Research|March 15, 1993
High-level expression of the ribosomal protein L19 in human breast tumors that overexpress erbB-2J L Henry, D L Coggin, C R King
Canadian Journal of Physiology and Pharmacology|August 1, 1990
Adrenal versus nonadrenal sympathetic preganglionic neurones in the lower thoracic intermediolateral nucleus of the cat: effects of serotonin, substance P, and thyrotropin-releasing hormoneS B Backman, H Sequeira-Martinho, J L Henry
European Journal of Pharmacology|July 11, 1996
SR 48968 specifically depresses neurokinin A- vs. substance P-induced hyperalgesia in a nociceptive withdrawal reflexK Yashpal, C W Hui-Chan, J L Henry
Diabetic Medicine : a Journal of the British Diabetic Association|February 26, 2020
Risk factors associated with progression to referable retinopathy: a type 2 diabetes mellitus cohort study in the Republic of IrelandJ J Smith, D M Wright, P Scanlon, et al.
British Journal of Pharmacology|March 1, 1997
The effects of spiradoline (U-62066E), a kappa-opioid receptor agonist, on neuroendocrine function in manE Ur, D M Wright, P M Bouloux, et al.
Pageof 42